glp 1 agonist in heart failure GLP-1 Agonists Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Treatment of High-Risk Patients with

participants reported significant decreases in body weight (32)

Were Leaping Bunny certified

When GLP-1 receptor agonists activate these receptors, they prevent the nuclear translocation of NF-kB

(2015) demonstrated that patients with large-artery atherosclerotic ischemic stroke and transient ischemic attack (TIA) exhibited significant gut dysbiosis, characterized by increased opportunistic pathogens (e.g., Enterobacter, Megasphaera, Desulfovibrio ) and reduced beneficial genera like Bacteroides and Faecalibacterium

10.1038/s41592-019-0509-5 21 ChowJ

Alterations on cellular redox states upon infection and implications for host cell homeostasis